Nuzenio

Enzomenib

Enzomenib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

FDA grants orphan drug status to potential treatment for ALL - Rare Cancer NewsRare Cancer News · Fri, 07 Aug 2026 18:08:50 GMTSumitomo Pharma's Enzomenib gets Orphan Drug Designation by US FDA - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 06:21:06 GMT【4506.T FY2026 Q1 Earnings Call】Net Profit ¥17 Billion, Up ¥5.8 Billion YoY; OrgoVix Momentum Puts $1 Billion Milestone in Sight, Dividend Mention Teed Up for Interim Results - finance.biggo.comfinance.biggo.com · Mon, 03 Aug 2026 06:37:00 GMTMenin Inhibitor Enzomenib Gains FDA Orphan Drug Designation in ALL - Targeted OncologyTargeted Oncology · Fri, 31 Jul 2026 19:06:27 GMTFDA grants Sumitomo Pharma enzomenib orphan drug designation for acute lymphoblastic leukemia - AllSciAllSci · Thu, 30 Jul 2026 16:38:27 GMTSumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia - Business WireBusiness Wire · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 18:08:50 GMTFDA grants orphan drug status to potential treatment for ALL - Rare Cancer News
Tue, 04 Aug 2026 06:21:06 GMTSumitomo Pharma's Enzomenib gets Orphan Drug Designation by US FDA - Indian Pharma Post
Mon, 03 Aug 2026 06:37:00 GMT【4506.T FY2026 Q1 Earnings Call】Net Profit ¥17 Billion, Up ¥5.8 Billion YoY; OrgoVix Momentum Puts $1 Billion Milestone in Sight, Dividend Mention Teed Up for Interim Results - finance.biggo.com
Fri, 31 Jul 2026 19:06:27 GMTMenin Inhibitor Enzomenib Gains FDA Orphan Drug Designation in ALL - Targeted Oncology
Thu, 30 Jul 2026 16:38:27 GMTFDA grants Sumitomo Pharma enzomenib orphan drug designation for acute lymphoblastic leukemia - AllSci
Thu, 30 Jul 2026 07:00:00 GMTSumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Enzomenib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.